Norges Bank Bio Rad Laboratories, Inc. Transaction History

Norges Bank

  • $772 Billion
  • Q2 2025

A detailed history of Norges Bank transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Norges Bank holds 128,408 shares of BIO stock, worth $35.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
128,408
Holding current value
$35.3 Million
% of portfolio
0.0%

Shares

52 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$216.56 - $256.68 $27.8 Million - $33 Million
128,408 New
128,408 $31 Million
Q4 2024

Feb 12, 2025
BUY
$313.15 - $374.28 $39.7 Million - $47.4 Million
126,766 New
126,766 $41.6 Million
Q2 2024

Aug 14, 2024
BUY
$268.26 - $339.48 $60.8 Million - $76.9 Million
226,567 New
226,567 $61.9 Million
Q1 2024

May 14, 2025
BUY
$304.11 - $351.99 $71.4 Million - $82.6 Million
234,806 New
234,806 $81.2 Million
Q4 2023

Feb 09, 2024
BUY
$269.37 - $365.04 $61 Million - $82.7 Million
226,523 New
226,523 $73.1 Million
Q3 2023

Nov 13, 2024
BUY
$350.25 - $422.63 $79.6 Million - $96 Million
227,258 New
227,258 $81.5 Million
Q3 2023

Nov 13, 2023
SELL
$350.25 - $422.63 $70.7 Million - $85.4 Million
-201,965 Closed
0 $0
Q2 2023

Aug 14, 2024
BUY
$359.49 - $486.4 $248,407 - $336,102
691 Added 0.3%
227,258 $86.2 Million
Q2 2023

Aug 14, 2023
SELL
$359.49 - $486.4 $71.1 Million - $96.2 Million
-197,743 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$418.69 - $503.0 $94.8 Million - $114 Million
226,330 New
226,330 $108 Million
Q4 2022

Feb 14, 2023
BUY
$351.71 - $456.01 $76.5 Million - $99.2 Million
217,467 New
217,467 $91.5 Million
Q3 2022

Nov 13, 2023
BUY
$412.59 - $563.26 $83.3 Million - $114 Million
201,965 New
201,965 $84.2 Million
Q2 2022

Aug 14, 2023
BUY
$463.67 - $597.16 $91.7 Million - $118 Million
197,743 New
197,743 $97.9 Million
Q1 2022

May 12, 2023
SELL
$524.57 - $735.42 $4.29 Million - $6.01 Million
-8,170 Reduced 3.76%
209,297 $118 Million
Q1 2022

May 09, 2022
SELL
$524.57 - $735.42 $112 Million - $157 Million
-213,286 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$708.84 - $794.68 $151 Million - $169 Million
213,286 New
213,286 $161 Million
Q3 2021

Nov 14, 2022
BUY
$657.71 - $825.77 $136 Million - $171 Million
206,860 New
206,860 $154 Million
Q3 2021

Nov 05, 2021
SELL
$657.71 - $825.77 $137 Million - $172 Million
-208,431 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$576.64 - $649.04 $120 Million - $135 Million
208,431 New
208,431 $134 Million
Q2 2021

Aug 10, 2021
SELL
$576.64 - $649.04 $121 Million - $137 Million
-210,497 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$547.01 - $662.35 $115 Million - $139 Million
210,497 New
210,497 $120 Million
Q1 2021

May 07, 2021
SELL
$547.01 - $662.35 $112 Million - $136 Million
-205,182 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$510.68 - $643.45 $105 Million - $132 Million
205,182 New
205,182 $120 Million
Q4 2020

Feb 10, 2021
SELL
$510.68 - $643.45 $113 Million - $143 Million
-222,014 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$454.43 - $535.6 $101 Million - $119 Million
222,014 New
222,014 $114 Million
Q3 2020

Nov 10, 2020
SELL
$454.43 - $535.6 $97.9 Million - $115 Million
-215,484 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$334.87 - $493.06 $72.2 Million - $106 Million
215,484 New
215,484 $97.3 Million
Q2 2020

Aug 07, 2020
SELL
$334.87 - $493.06 $70 Million - $103 Million
-208,929 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$320.01 - $409.07 $66.9 Million - $85.5 Million
208,929 New
208,929 $73.2 Million
Q1 2020

May 08, 2020
SELL
$320.01 - $409.07 $67.6 Million - $86.4 Million
-211,271 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$319.73 - $374.2 $67.5 Million - $79.1 Million
211,271 New
211,271 $78.2 Million
Q4 2019

Feb 12, 2020
SELL
$319.73 - $374.2 $67 Million - $78.4 Million
-209,496 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$304.55 - $345.24 $63.8 Million - $72.3 Million
209,496 New
209,496 $69.7 Million
Q3 2019

Nov 08, 2019
SELL
$304.55 - $345.24 $63.3 Million - $71.8 Million
-207,938 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$286.93 - $312.59 $59.7 Million - $65 Million
207,938 New
207,938 $65 Million
Q2 2019

Aug 09, 2019
SELL
$286.93 - $312.59 $59.7 Million - $65 Million
-207,938 Closed
0 $0
Q1 2019

May 11, 2020
BUY
$224.3 - $317.41 $1.89 Million - $2.68 Million
8,442 Added 4.23%
207,938 $63.6 Million
Q4 2018

Mar 04, 2019
BUY
$220.1 - $309.0 $43.9 Million - $61.6 Million
199,496 New
199,496 $46.3 Million
Q4 2018

Feb 08, 2019
SELL
$220.1 - $309.0 $42.3 Million - $59.4 Million
-192,133 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$289.28 - $326.15 $55.6 Million - $62.7 Million
192,133 New
192,133 $60.1 Million
Q3 2018

Nov 09, 2018
SELL
$289.28 - $326.15 $51.5 Million - $58.1 Million
-178,010 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$244.1 - $303.88 $43.5 Million - $54.1 Million
178,010 New
178,010 $51.4 Million
Q2 2018

Jul 23, 2018
SELL
$244.1 - $303.88 $43.9 Million - $54.6 Million
-179,698 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$233.97 - $274.11 $42 Million - $49.3 Million
179,698 New
179,698 $44.9 Million
Q1 2018

May 09, 2018
SELL
$233.97 - $274.11 $40.8 Million - $47.8 Million
-174,272 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$216.94 - $271.3 $37.8 Million - $47.3 Million
174,272 New
174,272 $41.6 Million
Q4 2017

Feb 09, 2018
SELL
$216.94 - $271.3 $37.8 Million - $47.3 Million
-174,272 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$212.27 - $242.28 $37 Million - $42.2 Million
174,272 New
174,272 $38.7 Million
Q3 2017

Nov 07, 2017
SELL
$212.27 - $242.28 $38.8 Million - $44.3 Million
-182,981 Closed
0 $0
Q2 2017

Jul 24, 2018
BUY
N/A
22,309 Added 13.88%
182,981 $41.4 Million
Q1 2017

May 11, 2018
SELL
N/A
-7,990 Reduced 4.74%
160,672 $32 Million
Q3 2016

Nov 13, 2017
BUY
N/A
168,662
168,662 $0

Others Institutions Holding BIO

# of Institutions
427
Shares Held
19.1M
Call Options Held
10.7K
Put Options Held
37.5K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.77B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email